SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-5.09%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$220M
AUM Growth
+$220M
(+15%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
17.1%
Top 10 Holdings %
Top 10 Hldgs %
81.25%
Holding
35
New
9
Increased
14
Reduced
7
Closed
4
Top Buys
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$36.2M |
| 2 |
Galapagos
GLPG
|
$12.8M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$5.99M |
| 4 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$5.02M |
| 5 |
Ovid Therapeutics
OVID
|
$4.21M |
Top Sells
| 1 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$32M |
| 2 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$8.17M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.27M |
| 4 |
Xoma
XOMA
|
$2.39M |
| 5 |
EyePoint Pharmaceuticals
EYPT
|
$2.33M |
Sector Composition
| 1 | Healthcare | 90.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $69.9M | 31.8% | 5,801,748 +3,004,004 | +107% | +$36.2M |
|
|
CTIC
2
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $23.5M | 10.69% | 7,964,329 +331,799 | +4% | +$979K |
|
|
ADMS
3
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $19.2M | 8.75% | 3,914,938 +1,220,643 | +45% | +$5.99M |
|
|
4
Galapagos
GLPG
$2.07B
| $12.8M | 5.85% | +244,205 | New | +$12.8M |
|
|
5
Ovid Therapeutics
OVID
$91M
| $10.9M | 4.97% | 3,252,892 +1,252,892 | +63% | +$4.21M |
|
6
Gyre Therapeutics
GYRE
$703M
| $10.8M | 4.93% | 2,635,014 -441,362 | -14% | -$1.81M |
|
|
SBBP
7
DELISTED
Strongbridge Biopharma plc.
SBBP
| $9.16M | 4.17% | 4,489,687 +1,184,070 | +36% | +$2.42M |
|
|
APEN
8
DELISTED
Apollo Endosurgery, Inc.
APEN
| $8.26M | 3.76% | 912,125 +149,942 | +20% | +$1.36M |
|
|
AFMD
9
DELISTED
Affimed
AFMD
| $7.18M | 3.27% | 1,161,466 +311,466 | +37% | +$1.92M |
|
|
GMDA
10
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $6.76M | 3.08% | 1,724,201 +1,280,694 | +289% | +$5.02M |
|
11
Exagen
XGN
$217M
| $5.31M | 2.42% | 390,637 +221,095 | +130% | +$3.01M |
|
12
Celcuity
CELC
$2.17B
| $5.3M | 2.41% | 294,692 +75,741 | +35% | +$1.36M |
|
|
KA
13
DELISTED
Kineta, Inc. Common Stock
KA
| $4.97M | 2.26% | 481,692 +39,733 | +9% | +$410K |
|
|
ATYR
14
aTyr Pharma
ATYR
$527M
| $3.73M | 1.7% | +410,535 | New | +$3.73M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| $3.49M | 1.59% | 200,000 | – | – |
|
16
Synlogic
SYBX
$17M
| $3.05M | 1.39% | +1,000,000 | New | +$3.05M |
|
17
Elicio Therapeutics
ELTX
$172M
| $2.74M | 1.25% | 280,183 +57,347 | +26% | +$560K |
|
18
Evolus
EOLS
$494M
| $2.29M | 1.04% | +300,000 | New | +$2.29M |
|
19
Avalo Therapeutics
AVTX
$122M
| $1.85M | 0.84% | +850,000 | New | +$1.85M |
|
20
Cidara Therapeutics
CDTX
$1.66B
| $1.75M | 0.8% | 782,817 -428,469 | -35% | -$960K |
|
|
21
Xoma
XOMA
$392M
| $1.7M | 0.77% | 68,542 -96,499 | -58% | -$2.39M |
|
22
Leap Therapeutics
LPTX
$12M
| $1M | 0.46% | +250,000 | New | +$1M |
|
|
ATRS
23
DELISTED
Antares Pharma, Inc.
ATRS
| $961K | 0.44% | +264,100 | New | +$961K |
|
|
24
EyePoint Pharmaceuticals
EYPT
$797M
| $839K | 0.38% | 80,537 -223,314 | -73% | -$2.33M |
|
25
DiaMedica Therapeutics
DMAC
$295M
| $665K | 0.3% | 165,775 -254,167 | -61% | -$1.02M |
|